Adverum Biotechnologies Inc is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. ADVM has around 6.8M shares in the U.S. ETF market. The largest ETF holder of ADVM is the SPDR S&P Biotech ETF (XBI), with approximately 2.07M shares. Investors may also find of interest that the ETF with the largest allocation to ADVM stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 2.23%. On average, U.S. ETFs allocate 0.26% of ADVM to their portfolios.
Additionally, ADVM is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ADVM as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.59%.